ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
ResMed (RMD) Tops Q2 EPS by 15c
January 28, 2021 4:06 PM ESTResMed (NYSE: RMD) reported Q2 EPS of $1.41, $0.15 better than the analyst estimate of $1.26. Revenue for the quarter came in at $800 million versus the consensus estimate of $783.18 million.
Our second-quarter results reflect continued solid performance and positive trends across our business resulting in top-line... More
